The HIV Clinical and Translational Research (HIV-CTR) Group focuses on clinically oriented research in the field of HIV, hepatitis and SARS-COV-2 and provides new translational knowledge in immunology.
The HIV Clinical and Translational Research (HIV-CTR) Group emerged from the Reference Laboratory of Retrovirology offering specialised technical support for the clinical follow-up of HIV and HCV-infected patients in Luxembourg since 1990. The group joined the Department of Infection and Immunity under the direction of Dr Carole Seguin-Devaux, and lead HIV clinical research in the field of resistance to antiviral therapy, transmission, molecular epidemiology and HIV Cure since 2014.
The HIV-CTR research team:
The Group is a partner in several European HIV and HCV networks, collaborates with lifescience and biotech companies, and has built up a network in Sub-Saharian African countries to support knowledge and technology transfer for the clinical management of HIV and hepatitis-infected patients.